Scientific program

14:00-14:30 Opening words

Chair of the Symposium Juha Sinisalo

Session 1 Recent development

chairman Juha Sinisalo

14:30-14:55

Genome-wide analysis: A critical approach

Mark Daly, Finland

15:00-15:25

Understanding relationships between diet, the microbiome and disease 

Rob Knight, USA

Session 2 Risk profiles and prevention 

chairman Katriina Aalto-Setälä

16:30-16:55

Sex differences in CVD

Nanette Wenger, USA

17:00-17:25

Genome-based prediction & prevention of cardiovascular disease – a practical approach

Elisabeth Widen, Finland

Session 3 Heart failure 1

chairman Jussi Naukkarinen

17:30-17:55

Widening spectrum of heart failure

Rudolf de Boer, Netherlands

Session 4 Coronary artery disease

chairman Juha Sinisalo

08:30-08:55

Novel imaging

Koen Nieman, USA

09:00-09:25

Gene therapies in CVD

Seppo Ylä-Herttuala, Finland

Session 5 Arrhythmias

chairman Kimmo Kontula

10:00-10:25

Cell and tissue modelling for atrial fibrillation

Lior Gepstein, Israel

10:30-10:55

Precision treatment of inherited cardiac channelopathies

Arthur Wilde, Netherlands

11:00-11:25

The molecular autopsy for SCDY

Michael J Ackerman, USA

Session 6 Heart failure 2

chairman Jussi Naukkarinen

15:30-15:55

Stem cell therapies

Gabor Foldes, UK

Session 7 Hypertension

chairman Timo Hiltunen

16:15-16:40

Refining future targets for antihypertensive treatment

Jan A Staessen, Belgium

16:45-17:10

Hypertension Precision Medicine

Sandosh Padmanabhan, UK

17:15-17:40

Device therapy in hypertension

Wilko Spiering, Netherlands

Session 8 Pharmacogenetics

chairman Mikko Niemi

09:00-09:25

Pharmacogenomics and cardiovascular precision healthcare

Mark Caulfield, UK

09:30-09:55

Personalized approach for statin treatment

Mikko Niemi, Finland

10:00-10:25

Implementing pharmacogenomics in clinical practice

Henk-Jan Guchelaar, Netherlands

Session 9 Futurology

chairman Juha Sinisalo

11:00-11:25 

iPSC as predictive models

Mark Mercola, US

11:30-11:55

Future of genome editing techniques in personalized treatment

Bruce Conklin, US

12:00 Closing words